Site articles.


Australia commits $500m for COVID-19 vaccine in Pacific & South East Asia

Vision 2020 Australia has welcomed the Australian Government’s announcement of an additional $500 million over three years to provide safe and effective COVID-19 vaccines in the Pacific and Southeast Asia. The funding will be used to distribute COVID-19 vaccine doses throughout the Indo-Pacific region and provide technical support to ensure vaccine safety, efficacy and quality […]

Read more →

RANZCO welcomes new President and launches the Heather G Mack Scholarship for Women

The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Council met via Zoom on Saturday 10 October 2020. The main orders of business were the approval of the College’s 2021-2023 Strategic Plan the approval of the College’s first-ever Sustainability Charter. Both these documents, plus the annual report are available on the RANZCO website. The […]

Read more →

Luxturna becomes first ever TGA approved gene therapy

In a landmark decision, the Therapeutic Goods Administration has approved use of the first ever gene therapy in Australia. Luxturna (voretigene neparvovec) is now registered in Australia, for the treatment of patients with inherited retinal dystrophy caused by pathological biallelic RPE65 mutations, who have sufficient viable retinal cells as determined by the treating physician. Luxturna […]

Read more →

50 per cent of people living with diabetes are missing out on diabetes eye checks to prevent blindness

A new University of Sydney study has found only half of people living with diabetes get the recommended diabetes eye checks putting them at risk of significant vision loss and blindness. Diabetes is the leading cause of blindness in working age Australians. All people with diabetes are at risk of diabetes related retinopathy which causes […]

Read more →